FIH, Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, Atopic Dermatitis, Chronic Rhinosinusitis, Nasal Polyps
Showing 9976 - 10000 of >10,000
Bladder Pain Syndrome, Interstitial Cystitis Trial in Worldwide (ASP6294, Placebo)
Completed
- Bladder Pain Syndrome
- Interstitial Cystitis
- ASP6294
- Placebo
-
Leuven, Belgium
- +27 more
Mar 10, 2020
SARS-CoV-2 Infection Trial in India (RP7214 + Standard of care (SOC), Placebo + Standard of care (SOC))
Completed
- SARS-CoV-2 Infection
- RP7214 + Standard of care (SOC)
- Placebo + Standard of care (SOC)
-
Bangalore, India
- +15 more
Apr 20, 2022
Diarrheal Disease, Infectious, Gastrointestinal Disease, Reactive Arthritis Trial in Debrecen (ShigETEC live, attenuated, oral
Completed
- Diarrheal Disease, Infectious
- +2 more
- ShigETEC live, attenuated, oral vaccine
- Placebo
-
Debrecen, HungaryDebreceni Egyetem, Klinikai Központ, Belgyógyászati Klinika, Kli
Jun 3, 2022
Pharmacokinetics Trial in Prague (Olanzapine film-coated tablets 5 mg (JSC Farmak, Ukraine), Zyprexa® coated tablets 5 mg (Eli
Completed
- Pharmacokinetics
- Olanzapine film-coated tablets 5 mg (JSC Farmak, Ukraine)
- Zyprexa® coated tablets 5 mg (Eli Lilly, Nederland B V)
-
Prague, CzechiaQUINTA-ANALYTICA s.r.o.
Nov 15, 2021
Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon TLR7/8
Recruiting
- Advanced Solid Tumor
- +6 more
- TransCon TLR7/8 Agonist
- Pembrolizumab
-
Duarte, California
- +12 more
Sep 21, 2022
Subjects With Cerebral Hemorrhage Trial in Guangzhou (Synbixin/Placebo)
Recruiting
- Subjects With Cerebral Hemorrhage
- Synbixin/Placebo
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital, Sun Yat-sen University
Jul 11, 2023
Human Immunodeficiency Virus (HIV) Trial in Rochester (Ixazomib 1 MG, Ixazomib 2 MG, Ixazomib 3 MG)
Completed
- Human Immunodeficiency Virus (HIV)
- Ixazomib 1 MG
- +3 more
-
Rochester, MinnesotaMayo Clinic
Dec 8, 2021
Bulevirtide Therapy in HDV Chronic Hepatitis in Italy
Completed
- Hepatitis D
-
Milan, MI, ItalyFoundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Divis
Jul 24, 2023
Nonsmall Cell Lung Cancer, NSCLC Trial in Worldwide (NovoTTF-200T, Immune checkpoint inhibitors or docetaxel)
Active, not recruiting
- Nonsmall Cell Lung Cancer
- NSCLC
- NovoTTF-200T
- Immune checkpoint inhibitors or docetaxel
-
Birmingham, Alabama
- +123 more
Oct 13, 2022
Malignant Tumor Trial in Houston (Isopropyl Alcohol, Placebo, Questionnaire Administration)
Not yet recruiting
- Malignant Neoplasm
- Isopropyl Alcohol
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Part I (SAD) - Healthy Participants, Part II (MAD) - COPD, Part III (J-SD) - Healthy Japanese Participants Trial in London,
Completed
- Part I (SAD) - Healthy Participants
- +2 more
- MEDI3506
- Placebo
-
London, United Kingdom
- +1 more
Sep 30, 2020
Lumbar Spinal Stenosis Trial in Salt Lake City (Amniotic Fluid Allograft, Dexamethasone sodium phosphate)
Recruiting
- Lumbar Spinal Stenosis
- Amniotic Fluid Allograft
- Dexamethasone sodium phosphate
-
Salt Lake City, Utah
- +1 more
Nov 22, 2022
COPD, Chronic Musculoskeletal Pain Trial in Boston (Every Step Counts-Tai Chi, Usual Care)
Not yet recruiting
- COPD
- Chronic Musculoskeletal Pain
- Every Step Counts-Tai Chi
- Usual Care
-
Boston, MassachusettsVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Jan 18, 2023
Relapsed or Refractory Acute Myeloid Leukemia Trial in Duarte, Houston (AMG 330, Pembrolizumab)
Terminated
- Relapsed or Refractory Acute Myeloid Leukemia
- AMG 330
- Pembrolizumab
-
Duarte, California
- +1 more
Dec 2, 2021